PCS for HB 731 — Drug-Related Overdose Prevention (Florida House of Representatives, 2022)
- Issuer
- Congressional materials
- Document type
- 2022 3093 Professions Public Health Subcommittee Proposed Committee Bills Pcbs Fn Pcs For
- Case
- 2022 3093 Professions Public Health Subcommittee Proposed Committee Bills Pcbs Fn Pcs For Hb 731
Summary
A proposed committee substitute, PCS for HB 731, from the Florida House of Representatives in 2022, a bill relating to drug-related overdose prevention. Section 1 amends s. 381.887, F.S., to authorize pharmacists to order certain emergency opioid antagonists and to extend immunity for administering them to personnel of law enforcement and other agencies who come into contact with controlled substances. Section 2 amends s. 381.981, F.S., adding emergency opioid antagonists to the substance abuse health awareness campaign. Section 3 amends s. 395.1041, F.S., to require hospital emergency rooms and urgent care centers that treat and release a person for a suspected or actual overdose to report the incident to the department, with best efforts to report within 120 hours. The act takes effect July 1, 2022; the bill is six pages.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“PCS for HB 731 — Drug-Related Overdose Prevention (Florida House of Representatives, 2022).”
Original at www.flhouse.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2022-3093-professions-public-health-subcommittee-proposed-committee-bills-pcbs-fn-pcs-for-hb-731/
, SHA-256 36da59b20f0ef1b634ffd3403a0b944297d328d48b2cd00390063f4e8030e5d1.Full text
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
PCS for HB 731 2022
1 A bill to be entitled
2 An act relating to drug-related overdose prevention;
3 amending s. 381.887, F.S.; revising the purpose of
4 specified provisions relating to the prescribing,
5 ordering, and dispensing of emergency opioid
6 antagonists to certain persons by authorized health
7 care practitioners; authorizing pharmacists to order
8 certain emergency opioid antagonists; providing
9 certain authorized persons immunity from civil or
10 criminal liability for administering emergency opioid
11 antagonists under certain circumstances; authorizing
12 personnel of law enforcement agencies to administer
13 emergency opioid antagonists under certain
14 circumstances; amending s. 381.981, F.S.; requiring a
15 health awareness campaign; amending s. 395.1041, F.S.;
16 requiring a hospital emergency room and urgent care
17 facility to report incidents involving a suspected or
18 actual overdose to the department under certain
19 circumstances; providing requirements for the report;
20 requiring hospital emergency rooms and urgent care
21 facilities to use best efforts to report such
22 incidents to the department within a specified
23 timeframe; providing an effective date.
24
25 Be It Enacted by the Legislature of the State of Florida:
Page 1 of 6
CODING: Words stricken are deletions; words underlined are additions.
hb0731-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
PCS for HB 731 2022
26 Section 1. Subsections (2), (3), and (4) of section
27 381.887, Florida Statutes, are amended to read:
28 381.887 Emergency treatment for suspected opioid
29 overdose.—
30 (2) The purpose of this section is to provide for the
31 prescribing, ordering, and dispensing prescription of emergency
32 opioid antagonists an emergency opioid antagonist to patients
33 and caregivers and to encourage the prescribing, ordering, and
34 dispensing prescription of emergency opioid antagonists by
35 authorized health care practitioners.
36 (3)(a) An authorized health care practitioner may
37 prescribe and dispense an emergency opioid antagonist to , and a
38 pharmacist may order an emergency opioid antagonist with an
39 autoinjection delivery system or intranasal application delivery
40 system for, a patient or caregiver for use in accordance with
41 this section., and
42 (b) A pharmacist pharmacists may dispense an emergency
43 opioid antagonist pursuant to a prescription by an authorized
44 health care practitioner. A pharmacist may dispense an emergency
45 opioid antagonist with such a prescription or pursuant to a non-
46 patient-specific standing order for an autoinjection delivery
47 system or intranasal application delivery system, which must be
48 appropriately labeled with instructions for use, pursuant to a
49 pharmacist's order or pursuant to a nonpatient-specific standing
50 order.
Page 2 of 6
CODING: Words stricken are deletions; words underlined are additions.
hb0731-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
PCS for HB 731 2022
51 (c) A such patient or caregiver is authorized to store and
52 possess approved emergency opioid antagonists and, in an
53 emergency situation when a physician is not immediately
54 available, administer the emergency opioid antagonist to a
55 person believed in good faith to be experiencing an opioid
56 overdose, regardless of whether that person has a prescription
57 for an emergency opioid antagonist.
58 (4) The following persons are authorized to possess,
59 store, and administer emergency opioid antagonists as clinically
60 indicated and are immune from any civil liability or criminal
61 liability as a result of administering an emergency opioid
62 antagonist:
63 (a) Emergency responders, including, but not limited to,
64 law enforcement officers, paramedics, and emergency medical
65 technicians.
66 (b) Crime laboratory personnel for the statewide criminal
67 analysis laboratory system as described in s. 943.32, including,
68 but not limited to, analysts, evidence intake personnel, and
69 their supervisors.
70 (c) Personnel of a law enforcement agency or other agency,
71 including, but not limited to, correctional probation officers
72 and child protective investigators who, while acting within the
73 scope or course of employment, come into contact with a
74 controlled substance or persons at risk of experiencing an
75 opioid overdose.
Page 3 of 6
CODING: Words stricken are deletions; words underlined are additions.
hb0731-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
PCS for HB 731 2022
76 Section 2. Subsection (2) of section 381.981, Florida
77 Statutes, is amended to read:
78 381.981 Health awareness campaigns.—
79 (2) The awareness campaigns shall include the provision of
80 educational information about preventing, detecting, treating,
81 and curing the following diseases or conditions. Additional
82 diseases and conditions that impact the public health may be
83 added by the board of directors of the Florida Public Health
84 Institute, Inc.; however, each of the following diseases or
85 conditions must be included in an awareness campaign during at
86 least 1 month in any 24-month period:
87 (a) Cancer, including breast, prostate, cervical, ovarian,
88 colorectal, and skin cancer and leukemia.
89 (b) Heart disease.
90 (c) Stroke.
91 (d) Lung disease, including asthma and smoking-relating
92 disease.
93 (e) Neurological disorders and disease, including
94 Alzheimer's disease, Parkinson's disease, and epilepsy.
95 (f) Gastrointestinal disease.
96 (g) Kidney disease.
97 (h) Diabetes.
98 (i) Liver disease.
99 (j) Autoimmune disorders.
100 (k) Birth defects and prenatal care.
Page 4 of 6
CODING: Words stricken are deletions; words underlined are additions.
hb0731-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
PCS for HB 731 2022
101 (l) Obesity and malnutrition.
102 (m) Sexually transmissible disease.
103 (n) Hepatitis A, hepatitis B, and hepatitis C.
104 (o) Arthritis.
105 (p) Vaccine-preventable diseases.
106 (q) Infectious diseases, including HIV/AIDS.
107 (r) Substance abuse, including, but not limited to,
108 emergency opioid antagonists.
109 (s) Mental illness.
110 (t) Lupus.
111 (u) Osteoporosis.
112 Section 3. Subsection (8) is added to section 395.1041,
113 Florida Statutes, to read:
114 395.1041 Access to emergency services and care.—
115 (8) REPORTING OF CONTROLLED SUBSTANCE OVERDOSES.—A
116 hospital emergency room or urgent care center that treats and
117 releases a person in response to a suspected or actual overdose
118 of a controlled substance must report such incident to the
119 department if the patient was not transported by a transport
120 service as defined in s. 401.23. Such reports must be made using
121 an appropriate method with secure access, including, but not
122 limited to, the Washington/Baltimore High Intensity Drug
123 Trafficking Overdose Detection Mapping Application Program ,
124 EMSTARS, or other program identified by department rule. If a
125 hospital emergency room or urgent care center reports such
Page 5 of 6
CODING: Words stricken are deletions; words underlined are additions.
hb0731-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
PCS for HB 731 2022
126 incidents, it must make its best efforts to make the report to
127 the department within 120 hours after knowledge of the incident.
128 Section 4. This act shall take effect July 1, 2022.
Page 6 of 6
CODING: Words stricken are deletions; words underlined are additions.
hb0731-00
File and source
- File
- 2022_3093_professions-public-health-subcommittee_proposed-committee-bills-pcbs_fn-pcs-for-hb-731.pdf
- Size
- 114,210 bytes
- SHA-256
- 36da59b20f0ef1b634ffd3403a0b944297d328d48b2cd00390063f4e8030e5d1
- Our copy
- 2022_3093_professions-public-health-subcommittee_proposed-committee-bills-pcbs_fn-pcs-for-hb-731.pdf
- Original
- www.flhouse.gov